Redmile Group, LLC Lava Therapeutics Nv Call Options Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.8MCall Options Held
85.8KPut Options Held
36.8K-
Bruce & Co., Inc. Chicago, IL772KShares$1.42 Million0.68% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$676,3500.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$206,8870.0% of portfolio
-
Pathway Financial Advisors LLC103KShares$188,6000.04% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$160,8100.08% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $47.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...